Stephen Kingsmore, President & CEO of Rady Children’s Institute for Genomic Medicine, is a household name for fast diagnosis and treatment of critically ill newborns. Applying whole genome sequencing (WGS) in Newborn Intensive Care Units (NICUs) to diagnose critically ill newborns via fast data analysis has resulted in success stories that were unthinkable just a few years ago. Clearly, WGS is revolutionizing the field of rare disease diagnosis and none of this would be possible without the underlying technological advancements. Kingsmore has applied his vision of translating these advancements into something deeply meaningful– saving the lives of newborns.

Combining different technologies and applying them to the critical need of an expedited diagnosis (within 25 hours) for newborns who are struggling to hold on to life, sounds like a straightforward task. But like most aspects of medicine, the real complexity reveals itself in the implementation.

Today Kingsmore and Rady Children’s Hospital’s implemented clinical workflow is considered the exemplary leader in pediatric genomic medicine, an example that is likely to become a model, not only for other NICUs, but for efficient whole genome sequencing in the general clinical setting. Panel sequencing in the clinical setting is an established approach, but WGS applications are lagging, mostly due to interpretation limitations. Rapid clinical WGS, however, is imperative in light of growing evidence of its utility in acute care, such as in diagnosis of genetic diseases in very ill infants, and genotype-guided choice of chemotherapy at cancer relapse. This is especially true in situations when delayed clinical decisions may mean the difference between life and death.

We are delighted to have Dr. Stephen Kingsmore join us at PMWC 2018 Silicon Valley in January, to share his vision of WGS, genomic medicine in healthcare, how he’s promoting WGS, and how we can translate some of his learnings into other applications.

In order to successfully achieve acceptance and uptake of WGS in the clinic we need secure, scalable, and fast solutions, in addition to knowledge extraction tools that diagnose and explain a disease, or help make decisions regarding the correct treatment choice. We have several sessions planned that address exactly these needs – here a few highlights:

  • Scalable NGS infrastructure/platforms
    • Scalable infrastructure/platforms integrating NGS and other data to power discovery and analysis in Pharma and the clinic – with session chair Brady Davis of DNAnexus
  • Expediting the analysis of clinical NGS data
    • Advancing clinical next-generation sequencing, chaired by Rebecca Hemenway of Edico Genome
      • Presenter: Alex Bisignano (Phosphorus), Bruce Quinn (Bruce Quinn Associates), Melanie Nallicheri (Foundation Medicine)
    • Expediting patient diagnosis and treatment with AI and machine learning with chair Eric Schadt of Sema4
      • Presenter: Jessica Meg (Verily), Thomas Wilckens (InnVentis), Jurgi Camblong (Sophia Genetics)
  • NGS Data analysis solutions
    • Applying machine learning to deliver value for a range of healthcare stakeholders, chaired by Diane Wuest of GNS Healthcare
    • The challenges and rewards of bringing AI into the clinic for health & disease management with chair Chris Cournoyer of N-of-One
      • Presenters: Yarmela Pavlovic (Hogan Lovells), Jeff Boyd (Baptist Health South Florida), Sheryl Elkin (N-of-One), Andrew Beck (PathAI)
    • How AI will Cure Cancer chaired by Marty Tenenbaum of Cancer Commons
    • Delivering laboratory reports that translate into clinical actions for oncologists, which is chaired by John Shon of Illumina
      • Presenters: Richard Schilsky (ASCO), Lincoln Nadauld (Intermountain)
    • State of genomics-guided clinical decision support, chaired by Sean Scott of Qiagen
      • Presenter: Raju Pillai (City of Hope National Medical Center), Alejandro Sweet-Cordero (UCSF)
    • Enabling precision medicine through automated literature analysis with chair Mark Kiel of Genomenon
  • Precision Medicine + All of Us Research Program
    • An entire track that focuses on large scale whole genome initiatives– the learnings, the challenges, and the needs
      • Biospecimens as building blocks for precision medicine discovery, with chair Chris Ianelli, iSpecimen
      • AACR Project GENIE: An international Cancer Registry. Chair: Alexander Baras, Johns Hopkins Hospital
      • Data sharing & protection with Hector Rodriguez, Microsoft
      • Precision medicine initiative status in Germany with Erwin P. Bottinger, Hasso-Plattner-Institute GmbH
      • All of Us Research Program Sessions with chair Stephanie Devaney, NIH
      • Large scale sequencing and genetics initiatives with chair Aris Baras, Regeneron
      • An update from the California PM initiative with chair India Hook-Barnard, UCSF
  • Find the full program with all speakers here.

We also have a series of Company Showcases that highlight exciting commercial developments in whole genome NGS solutions, including:

  • Wellness and Aging
  • Emerging Therapeutics
  • Microbial
  • Clinical Dx
  • Liquid Biopsy
  • AI / Machine Learning
  • Immunotherapy
  • Genomic Profiling

Don’t miss out. Join us January 22 – 24 at the Computer History Museum in the heart of the Silicon Valley, for PMWC 2018 SV.

Join us now!

Late breaking: Dawn Barry leaves Illumina to lead Luna DNA -Blockchain Disrupting Healthcare Industry

“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together will more quickly aggregate enough samples to rise above the complexity of genomics and identify disease candidates.” – Dawn Barry, President and Co-Founder, Luna DNA

Read More

Interview Dawn Barry the new President and Co-founder of Luna DNA

Q: In a sentence, what is Luna DNA going to do?

Read More

JPM18: Edico Genome, Illumina, Invitae, Regeneron, Thermo Fisher Scientific,… and the list goes on

It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week!

Read More

At PMWC 2018 Silicon Valley CMS Administrator Seema Verma Discusses the Future of Health Care

Genomics-based testing or new immunotherapies that revolutionize cancer care are changing how we approach disease…

Read More

Interview with Dr. Frank Lee, Global Healthcare & Life Sciences Industry Leader at IBM; Chief Architect, IBM Reference Architecture for Genomics – Speaker at PMWC 2018 Silicon Valley

Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives?

Read More

Q&A with Ira Mellman, PhD, Vice President, Cancer Immunology, Genentech – Speaker at PMWC 2018 Silicon Valley

Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?

Read More

Interview with Atul Sharan, Co-founder and CEO, CellMax Life

Q: CellMax has developed non-invasive blood tests based on Circulating tumor cells CTC. How do you see these tests being adopted clinically?

Read More

Q&A with Matthew Kane, Co-founder & CEO, Precision BioSciences – Speaker at PMWC 2018 Silicon Valley

Q: What are the benefits of the Precision BioSciences’ ARCUS genome editing platform and what makes it unique?

Read More

Q&A with Jon Heimer, CEO, Olink Proteomics – Speaker at PMWC 2018 Silicon Valley

Q: Olink has been rapidly growing its’ library of human protein biomarker assays. What are the popular clinical applications for your biomarker panels?

Read More

2017 Review: A Clear Paradigm Shift from a one-size-fits-all model to personalized healthcare

2017 saw technology innovations, new therapies and diagnostics, value-based healthcare, and clinical protocol advancements as huge drivers, moving the needle…

Read More

Q&A with Peter Donnelly, Director, Wellcome Trust Centre for Human Genetics (Oxford) – Speaker at PMWC 2018 Silicon Valley

Q: How will genomics transform healthcare and how will it impact medicine? Beyond genetics and genomics what other data is relevant and why?

Read More

PMWC Interview with Janusz Dutkowski, Ph.D., Co-founder & CEO, Data4Cure – Speaker at PMWC 2018 Silicon Valley

Q: What are some of the key unique ideas behind the Biomedical Intelligence Cloud? What contextual knowledge do you bring in?

Read More

Q&A with Bob Terbrueggen, President & CEO, DxTerity – Speaker at PMWC 2018 Silicon Valley

Q: What are the challenges that the field of genomic research will face in the next five years?

Read More

Q&A with Mark Kiel, CSO and Co-founder, Genomenon – Speaker at PMWC 2018 Silicon Valley

Q: What are the challenges facing clinical interpretation of NGS data today?

Read More

Precision Medicine Jan 22-24th – learn from the experts at PMWC Silicon Valley 2018

Genomic Data Analysis / Next-Gen Sequencing, Immunotherapy / Cancer Care, & Artificial Intelligence / Machine Learning are all extensively covered at the conference, January 22-24

Read More
University of Michigan

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
    • Immuno-oncology
    • Cancer and rare disease diagnostics
    • Biomarker and companion diagnostics
    • Big data approaches
    • NGS applications
    • AI and machine learning applications
    • Advancements in liquid biopsy applications
    • Wellness & Aging
    • CRISPR
    • The human microbiome
    • Infectious disease ID and monitoring
    • The importance of patient engagement
    • 3-D technologies
    • Updates on data and regulatory policies
    • Metabolomics in precision medicine
    • mHealth and Telehealth

About us:
The Precision Medicine World Conference (PMWC), in its 13th installment, will take place in Silicon Valley on January 22-24, 2018. The program will traverse innovative technologies, thriving initiatives, and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Conference attendees will have an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.

Agenda highlights:

    • More than 70 sessions with 350+ thought-provoking, insightful talks that cover all facets of precision medicine
    • Four tracks will showcase sessions on the latest advancements in precision medicine which include, but are not limited to:
        • Immuno-oncology
        • Cancer and rare disease diagnostics
        • Biomarker and companion diagnostics
        • Big data approaches
        • NGS applications
        • AI and machine learning applications
        • Advancements in liquid biopsy applications
        • Wellness & Aging
        • CRISPR
        • The human microbiome
        • Infectious disease identification and monitoring
        • The importance of patient engagement
        • 3-D technologies
        • Updates on data and regulatory policies
        • Metabolomics in precision medicine
        • mHealth and Telehealth

One track will be dedicated to the various aspects of the All of Us Research Program, while another session will focus on educating California’s legislators.

 

Confirmed thought leaders include:

Sir John Bell

Sir John Bell

Regius Professor of Medicine, Oxford University

sally-davies

Dame Sally Davies

Chief Medical Officer, Department of Health, UK Government

BLA00002-Elizabeth-Blackburn

Elizabeth Blackburn

Nobel Laureate, President, Salk Institute for Biological Studies

George-Sledge

George Sledge

Professor, Division Chief, Stanford University Medical Center

Jeffrey Bluestone

Jeffrey Bluestone

CEO and President, Parker Institute for Cancer Immunotherapy

Christopher Ianelli

Christopher Ianelli

Founder and Chief Executive Officer,  iSpecimen

Kenneth J. Pienta

Kenneth J. Pienta

Director, Brady Urological Institute, Johns Hopkins Medicine

Roy Beveridge

Roy Beveridge

Senior Vice President & Chief Medical Officer, Humana

Kimberly Blackwell

Kimberly Blackwell

Professor of Medicine, Assistant Prof. of Radiation Oncology, Duke Cancer Institute

Joshua Denny

Joshua Denny

Professor of Biomedical Informatics & Medicine, Vanderbilt University Medical Center

Edward S. Kim

Edward S. Kim

Chair, Solid Tumor and Investigational Therapeutics, Levine Cancer Institute

Howard L. McLeod

Howard L. McLeod

Medical Director, Personalized Medicine Institute, Moffitt Cancer Center

Lee Newcomer

Lee Newcomer

SVP, UnitedHealthcare Oncology and Genetics

Vinod Khosla

Vinod Khosla

Partner and Founder of Khosla Ventures

Troy Brennan

Troy Brennan

Executive VP & CMO, CVS Health

Ira Mellman

Ira Mellman

VP, Cancer Immunology, Genentech

Event Highlights

When
January 22, 2018 8:00am to January 24, 2018 5:00pm
Where
Computer History Museum
1401 N Shoreline Blvd
Mountain View, CA 94043
Cost
$1850 by January 19th, 2018
Registration
3-Day Access to Talks, Exhibition & Reception:
See Registration Details

Registration: PMWC Conferences

Silicon Valley Jan 22-24, 2018

65+ Sessions 4 Tracks
350+ Speaker lineup
Access to the exhibition
Breakfast & lunch refreshments
Networking App
Award Reception

Having Trouble Registering? We accept all major credit cards. Select 'PayPal Check out' and press 'Pay with Debit or Credit Card'.
Click here or call (650)-961-8877 to contact the PMWC Team for Help.